Filing Details
- Accession Number:
- 0001161697-22-000549
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-15 17:00:59
- Reporting Period:
- 2022-11-11
- Accepted Time:
- 2022-11-15 17:00:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763511 | Brian Elsbernd | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Chief Compliance/Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-11 | 14,666 | $16.24 | 11,096 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-11-14 | 65,000 | $1.85 | 76,096 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-11-14 | 40,000 | $0.79 | 116,096 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2022-11-14 | 65,000 | $0.00 | 65,000 | $1.85 |
| Common Stock | Options to purchase common stock | Disposition | 2022-11-14 | 40,000 | $0.00 | 40,000 | $0.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 885,667 | 2023-02-16 | No | 4 | M | Direct | |
| 845,667 | 2023-06-15 | No | 4 | M | Direct |
Footnotes
- Shares were sold for personal reasons and to raise funds for option exercises and not as a result of any disagreement with the Registrant. Mr. Elsbernd remains an officer of the Company.
- Shares were sold in various lots from $16.23 to $16.265 per share. Price shown represents a weighted average sale price.
- Options vested in three equal tranches on February 16, 2017, 2018 and 2019.
- Options vested in two equal tranches on June 15, 2017 and 2018.
Billionaire Hedge Funds
